A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC). BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ...

Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST ...

Dow Jones Top Company Headlines at 1 PM ET: Walmart Reaches $1 Trillion Market Cap as Its E-Commerce Booms | Disney ... The retailer has joined a select group of mostly tech companies with a 13-figure ...

Rheumatologists share how they are using AI platforms for clinical documentation, reducing EHR time, streamlining workflows, ...

null ...

Author Table of Contents Media Contact For general and media inquiries and to book our experts, please contact: ...

Company to Participate in BIO Partnering Summit and Present Phase 1 Ketamir-2 Data at American Association for Cancer ...

The Department of Health and Human Services (HHS) will invest $100 million to improve homelessness, opioid addiction and ...

Veradermics is set to raise $200 million in an IPO to fund its novel extended-release oral minoxidil for pattern hair loss.

The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in ...

Deficiencies limited to packaging and administrationCompany believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3 ...

With federal funding gone, a multipronged community effort is underway in the town of Fayetteville, Arkansas, to maintain food access.